Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness
NA Goldenberg, A Sochet, M Albisetti… - … of Thrombosis and …, 2020 - Wiley Online Library
Background Observational studies indicate that children hospitalized with COVID‐19‐
related illness, like adults, are at increased risk for venous thromboembolism (VTE). A …
related illness, like adults, are at increased risk for venous thromboembolism (VTE). A …
[HTML][HTML] SARS‐COV‐2–associated coagulopathy and thromboembolism prophylaxis in children: A single‐center observational study
G Del Borrello, I Giraudo, C Bondone, M Denina… - Journal of Thrombosis …, 2021 - Elsevier
Background Multiple investigators have described an increased incidence of
thromboembolic events in SARS‐CoV‐2–infected individuals. Data concerning hemostatic …
thromboembolic events in SARS‐CoV‐2–infected individuals. Data concerning hemostatic …
[HTML][HTML] COVID‐19 anticoagulation recommendations in children
M Loi, B Branchford, J Kim, C Self… - Pediatric blood & …, 2020 - ncbi.nlm.nih.gov
To the Editor: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is often associated with hypercoagulability …
syndrome coronavirus 2 (SARS-CoV-2) infection, is often associated with hypercoagulability …
Children and young adults hospitalized for severe COVID‐19 exhibit thrombotic coagulopathy
WB Mitchell, J Davila, J Keenan… - Pediatric Blood & …, 2021 - Wiley Online Library
We report the clinical and laboratory coagulation characteristics of 27 pediatric and young
adult patients (2 months to 21 years) treated for symptomatic COVID‐19 at a children's …
adult patients (2 months to 21 years) treated for symptomatic COVID‐19 at a children's …
[HTML][HTML] Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
GD Barnes, A Burnett, A Allen, J Ansell… - Journal of thrombosis …, 2022 - Springer
Thromboembolism is a common and deadly consequence of COVID-19 infection for
hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and …
hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and …
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of …
Abstract Background: COVID-19–related critical illness is associated with an increased risk
of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the …
of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the …
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of …
Abstract Background: COVID-19–related acute illness is associated with an increased risk of
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
Thrombotic risk in children with COVID-19 infection: a systematic review of the literature
M Zaffanello, G Piacentini, L Nosetti, S Ganzarolli… - Thrombosis …, 2021 - Elsevier
Objective Coagulation and inflammatory parameters are mildly altered in children with
SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and …
SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and …
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in …
syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in …
相关搜索
- anticoagulant thromboprophylaxis covid 19
- anticoagulant thromboprophylaxis clinical recommendations
- clinical recommendations covid 19
- children with covid 19 infection
- american society covid 19
- anticoagulant therapy thromboembolic prevention
- prophylaxis in children sars cov
- thrombotic coagulopathy young adults
- thrombosis in children covid 19
- thromboprophylaxis in patients covid 19
- rate of thrombosis covid 19
- thromboembolism anticoagulation covid 19
- use of anticoagulation covid 19